The Diabetes Prevention Program (DPP) is effective for the prevention of type 2 diabetes by weight loss with diet and physical activity. However, there is little evidence as to whether this program could be translated into real-world clinical practice in Latin American countries. The objective of this work was to evaluate the effectiveness of the DPP for the management of overweightness and obesity at 6 and 12 months in clinical practice in Mexico. This was a non-controlled intervention study implemented in five public clinics in northern Mexico. Two hundred and thirty-seven adults aged 45.7 ± 9.9 years with a Body Mass Index (BMI) of 34.4 ± 5.4 kg/m² received group sessions with an adaptation of the DPP, in addition to nutrition counseling. One hundred and thirty-three (56%) participants concluded the 6 month phase. They showed a significant weight loss, ranging from 2.76 ± 4.76 to 7.92 ± 6.85 kg (p ≤ 0.01) in the clinics. The intention-to-treat analysis showed a more conservative weight loss. Participant retention at the end of 12 months was low (40%). The implementation of the DPP in different public clinics in Mexico was effective in the management of obesity in the short term, but better strategies are required to improve participant retention in the long term.

Reducing ≥5% of body weight can decrease the risk of developing chronic diseases in adults with excess weight. Although Intensive Lifestyle Interventions (ILIs) that include cognitive-behavioral techniques to improve physical activity and eating habits are the best approach for losing weight, the failure to retain participants is a barrier to their successful implementation. We aimed to investigate the factors influencing adults to drop out of ILIs for weight loss at six months. We conducted retrospective multiple logistic regression analysis of 268 participants with excess weight (body mass index ≥ 25 kg/m²) from a multicenter study (n = 237, in-person ILI in five clinics, delivered by nutrition interns), and a randomized controlled trial (n = 31, one online ILI, delivered by a master’s degree student). The same research team conducted both studies in Northern Mexico, using the same intervention components, and identical instruments and techniques to collect the data. We found that older participants (≥50 years) were less likely to drop out of the ILI for weight loss compared to participants <35 years old (OR = 0.34, 95% CI = 0.16–0.70). For each unit increase in the bodily pain scale of the SF-36 (less perceived pain), the risk of dropping out decreased by 2% (OR = 0.98, 95% CI = 0.97, 0.996), while a change in the interventionist during the 6-month intervention more than doubled the risk of dropping out (OR 2.25, 95% CI = 1.23–4.14). Retention in ILIs may be improved by ensuring that the same interventionist remains during the six-month intervention. In addition, ILIs may need further tailoring for younger ages and for participants with higher perceived pain. Weight loss is hard. The best way to do it is to enroll in an intervention that includes frequent sessions with a health coach who uses cognitive-behavioral techniques to help participants improve their eating and physical activity habits. Retaining participants in these types of intervention is a challenge for health practitioners and researchers. Our objective was to identify the factors that increase the participants’ risk of dropping out of the intervention. We analyzed the data of 268 Mexican adults who participated in studies that evaluated intensive lifestyle interventions for weight loss. We found that participants who are younger, experience more pain, and whose health coaches are replaced before the intervention is completed have a higher risk of dropping out of the intervention. By accounting for these factors when designing the intervention, we could increase the chances that participants stay in the intervention until the end. This way they are more likely to be successful in losing weight.

Docosahexaenoic acid (DHA) is a long-chain omega-3 fatty acid essential for neurodevelopment, immune regulation, and key physiological functions during early life. In low- and middle-income countries (LMICs), limited access to DHA-rich foods contributes to disparities in intake and health outcomes. This narrative review describes the current evidence on dietary patterns of DHA intake and supplementation from pregnancy through childhood in LMICs and highlights the implications of these patterns for child health. The review is based on a systematic search conducted in PubMed using Medical Subject Heading (MeSH) terms related to DHA, dietary patterns, health outcomes, and LMICs. Studies published between 2014 and 2025 were screened using Covidence software. Eligible studies included observational, interventional, and review designs that reported DHA through dietary intake, supplementation, or measurement in biological samples during pregnancy, lactation, infancy, or childhood. Data extraction followed the PICOS (Population, Intervention, Comparison, Outcome, Study Design) framework. A total of 76 studies were included. Across LMICs, DHA intake was consistently insufficient among pregnant and lactating women, infants, and children. Reported dietary sources were generally low in DHA content. Intake or supplementation was associated with neurodevelopment, immune response, pregnancy outcomes, and cardiometabolic health, although findings were sometimes mixed or modified by gene–environment interactions. Results varied by study design, contextual factors, income level, and geographic access. Large gaps remain in nationally representative intake data. Despite its physiological relevance, DHA intake remains inadequate in LMICs during early life. This review underscores the importance of improving DHA intake in vulnerable populations and identifies evidence gaps to guide future research and inform context-specific nutrition strategies.

Introduction: Evidence suggests that the type of adipose tissue distribution contributes to a higher risk of developing cardiovascular diseases. It has been observed that visceral adipose tissue is highly lipolytic, and lipid distribution is primarily directed towards the liver, resulting in an excessive flow of fatty acids that can trigger lipid alterations and a high risk of hepatic steatosis. Objective: This study aimed to find the association of liver enzymes and lipid profile with body fat distribution in Mexico university students. Materials and methods: Cross-sectional, descriptive, and correlational study with a sample of university students aged 18 to 26 years. Anthropometric measurements, a 24-hour dietary recall (R24h), Pittsburgh sleep quality index, body fat determination, DXA-derived visceral adipose tissue (cm²) and subcutaneous adipose tissue (g), and blood samples were collected to determine lipid profile (low-density lipoprotein [LDL], high- density lipoprotein [HDL], very low-density lipoprotein [VLDL], triglycerides [TG], total cholesterol [TC]) and liver enzymes (aspartate aminotransferase [AST], alanine aminotransferase [ALT], and gamma-glutamyl transferase [-GT]). Results: We found a positive association between the type of fat distribution and LDL, VLDL, TC, TG, ALT, and -GT, indicating that higher visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), and body mass index (BMI) increase the concentrations of these biochemical parameters. In contrast, HDL showed a negative association, decreasing with an increase in VAT, SAT, and BMI. Conclusions: Body fat distribution (VAT and SAT) influences the lipid (LDL, VLDL, TC, TG, and HDL) and liver (ALT and -GT) levels of university students, which may indicate metabolic alterations.

Docosahexaenoic acid (DHA) is a long-chain omega-3 polyunsaturated fatty acid essential for maintaining optimal brain and cardiometabolic health across adulthood and aging. Despite its biological relevance, global evidence indicates substantial variability in DHA intake and status, largely influenced by dietary patterns, food availability, and socioeconomic conditions. This narrative review synthesized observational and interventional studies published between 2014 and 2026 that evaluated DHA intake or biomarkers in adults and older adults, emphasizing disparities according to country income level. Studies were categorized following the World Bank Gross National Income (GNI) classification and analyzed to describe intake patterns, biochemical concentrations, and their reported health associations. Important inequities were observed between countries. Populations in high-income countries (HICs) generally reported higher DHA intake and tissue concentrations, mainly due to regular fish consumption and greater access to supplementation, while evidence from middle-income countries (MICs) was scarce, heterogeneous, and based on small non-representative samples. In HICs, even moderate fish intake significantly improved DHA status, whereas in MICs, mean intakes frequently fell below 200 mg/day, a threshold commonly associated with cardiometabolic and neurocognitive benefits. Higher DHA levels were consistently linked to more favorable lipid profiles, lower triglyceride concentrations, and better cardiovascular indicators, though associations with blood pressure and mortality were inconsistent. Evidence from neurocognitive studies suggested structural and functional advantages, including larger total brain volume, improved white matter integrity, and enhanced cognitive performance, yet findings on memory and dementia outcomes remain inconclusive. Overall, this narrative review highlights global inequities in DHA intake and data availability, particularly in MICs, where national nutrition surveillance remains limited. These disparities may contribute to unequal protection against cardiovascular and neurocognitive decline. Strengthening dietary monitoring, improving access to DHA-rich or fortified foods, and promoting supplementation in vulnerable populations are key strategies to reduce inequities and support healthy aging worldwide.